Metabolomics – Your Life and Death is Written in Your Blood (B100)

In 1999, I invented an advanced mass spectrometry technology platform that could simultaneously measure thousands of small molecules called metabolites, or biochemicals, in biological samples like human blood. I used this technology to analyze tens of thousands of human blood samples from across the world. These samples were taken from persons in various stages of health and disease as well as longitudinally prior to disease incidence or death. This technology continues to be the most advanced of its kind today. Using this technology, I discovered numerous biochemical systems associated with disease and death, as well as those related to health, longevity, and vitality. This technology allowed me to perform the equivalent of a forensic audit, but instead of analyzing every line of income and expenses, I could measure all the biochemical transactions occurring in the human body. 

To access the FREE seminars with full presentations and videos please visit Dr. Goodenowe’s resource site here. This is the article for seminar B100, Blood Tests and Biomarkers (Series B).

I am an expert in all aspects regarding the design and development of targeted metabolite methods using all types of technologies, including liquid chromatography linked to ultra-violet, fluorescence, electrochemical and mass spectrometric detection technologies and gas chromatography linked to flame ionization, nitrogen-phosphorus, and mass spectrometric detection technologies. I have developed hundreds of targeted metabolite detection methods. Developing these tools was key to my research interests in various biochemical systems. Therefore, this pre-existing knowledge and experience made me uniquely qualified to recognize the seismic impact massively parallel genomic technologies would have on science. It also exposed a fatal flaw in the current practice of biochemistry. How can we expect to understand biochemistry if we cannot effectively measure what is happening at the biochemical level under conditions of disease or stress? I realized that an essential tool was missing. To do comprehensive biology, I needed a technology that could measure thousands of biochemicals simultaneously. Since that technology did not exist, I had to stop and create it. Based on the fundamental nature of metabolites, a comprehensive metabolite analysis technology had to be truly non-targeted. This technology could not be a massively parallel targeted technology like genetics-based technologies. I started thinking about how to invent such a technology in the late 1990s and it took me several years to solve the puzzle. I finally solved it in 1999 and then patented it in 2000. The core of the platform is ultra-high-resolution mass spectrometry. At the time, the only mass spectrometry technology that could achieve the resolution I needed was an ion cyclotron. It sounds complicated. And some parts of it are. But conceptually, the technology is straightforward and robust.  

Generally, when people think of chemistry they think of the periodic table of the elements where each element has an atomic mass based on the number of protons and neutrons in the nucleus of the atom. Accordingly, the mass of each unique element generally refers to their nominal mass such that carbon has a mass of 12, nitrogen, 14, oxygen, 16, and so on. However, the true mass of an atom is its isotopic mass, and only carbon has an isotopic mass equal to its nominal mass because carbon is used as the reference mass to which all other isotopic masses are compared. The true mass of nitrogen is 14.00307, the true mass of hydrogen is 1.007825, and the true mass of oxygen is 15.99491. Therefore, every unique combination of atoms will have a unique true mass. For example, glucose has a molecular formula of C6H12O6, which is typically referred to by its nominal mass of 180 and has an isotopic mass of 180.06336. Therefore, if I could achieve a high enough resolution to separate isotopic masses from each other and high enough mass accuracy to measure the mass to four decimal places or more, I could mathematically derive the molecular formula for any metabolite without any a priori knowledge of the metabolite. More importantly, I could do this for all the metabolites simultaneously in a biological sample. Also, once this core capability was achieved, I could do other amazing things such as building de novo biochemical pathways, simultaneously tracking drug metabolism with endogenous metabolite changes. It was mind-blowing. 

ProdromeScan™ is the commercial version of my patented, comprehensive non-targeted metabolomics technology, combined with key traditional biochemical markers. I designed ProdromeScan to be the gateway blood test for people who want to be in control of their health by becoming more involved in their biochemical health. The plethora of blood testing services available to the public is intimidating, and the biochemical interpretations of many of these tests are incomplete, misleading, and in some cases wrong. ProdromeScan measures the most important biomarkers for optimized health and longevity, and it includes all the important plasmalogens. Since ProdromeScan is derived from my comprehensive non-targeted metabolomics technology, it includes biomarkers that you cannot get anywhere else.  

Dr. Goodenowe explains and illustrates the power of metabolomics in seminar B100 – Metabolomics – Your Life and Death is Written in Your Blood.

Share on facebook
Share on twitter
Share on linkedin
Your privacy is important to us.

To better protect your privacy, we provide this notice explaining our online information practices and the choices you can make about the way your information is collected and used. To make this notice easy to find, we make it available on our homepage and at every point where personally identifiable information may be requested.

Collection of Personal Information

When visiting, the IP address used to access the site will be logged along with the dates and times of access. This information is purely used to analyze trends, administer the site, track users’ movement and gather broad demographic information for internal use. Most important, any recorded IP addresses are not linked to personally identifiable information.

Links to Third-Party Websites
We have included links on this site for your use and reference. We are not responsible for the privacy policies on these websites. You should be aware that the privacy policies of these sites may differ from our own.
Our Use of Google Analytics
The Dr. Dayan Goodenowe website uses the Google Analytics tool to measure traffic on the site and traffic to the site via our online advertising. This includes using certain Advertising Features, which enable Google Analytics to collect data about users via Google advertising cookies and identifiers, in addition to anonymous data collected through the standard Google Analytics implementation. These Advertising Features, which may or may not be currently using, include:
  • Remarketing with Google Analytics. This allows us to display our ads to you as you search online for similar businesses.
  • Google Display Network Impression Reporting, which shows which of our ads users click on.
  • Google Analytics Demographics and Interest Reporting, which provides information about the age and gender of site users, along with the interests they express in their online travel and purchasing activities.
  • Integrated services that require Google Analytics to collect data via advertising cookies and identifiers.
We do not merge personally identifiable information with non-personally identifiable information collected through any Google advertising product or feature unless we have obtained robust notice of, and the user’s prior affirmative (i.e., opt-in) consent to, that merger. These Advertising Features, which may or may not be currently using, include:
Opt Out

There are several ways to opt out of interest-based advertising and/or all tracking related to Google Analytics and its advertising features.

You can opt out of interest-based ads by Google through Ads Settings. When you opt out, you’ll still see ads but they may not be related to factors such as your interests, previous visits to other websites, or demographic details. Obtain instructions here.

The Network Advertising Initiative offers a free tool that allows users to opt out from receiving interest-based ads from some or all NAI participating member companies that use cookies on your computer browser to collect data for interest-based advertising. Find information about it here.

Website visitors can totally block Google Analytics with the Google Analytics opt-out browser add-on (click to download). This add-on instructs the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) running on websites to prohibit their information from being used by Google Analytics. Using the Google Analytics opt-out plug-in will not prevent site owners from using other tools to measure site analytics. Learn more about about the opt-out and how to properly install the browser add-on here.

Changes to this Privacy

Statement The contents of this statement may be altered at any time, at our discretion.

If you have any questions regarding the privacy policy of then you may contact us at

terms of use
Welcome to our website. If you continue to browse and use this website, you are agreeing to comply with and be bound by the following terms and conditions of use, which together with our privacy policy govern’s relationship with you in relation to this website. If you disagree with any part of these terms and conditions, please do not use our website.

The term ‘’ or ‘us’ or ‘we’ refers to the owner of the website whose registered office is:

40880 County Center Drive
Suite R
Temecula, CA 92591, USA

The term ‘you’ refers to the user or viewer of our website.

The use of this website is subject to the following terms of use:

The content of the pages of this website is for your general information and use only. It is subject to change without notice.

Neither we nor any third parties provide any warranty or guarantee as to the accuracy, timeliness, performance, completeness or suitability of the information and materials found or offered on this website for any particular purpose. You acknowledge that such information and materials may contain inaccuracies or errors and we expressly exclude liability for any such inaccuracies or errors to the fullest extent permitted by law.

Your use of any information or materials on this website is entirely at your own risk, for which we shall not be liable. It shall be your own responsibility to ensure that any products, services or information available through this website meet your specific requirements.

This website contains material which is owned by or licensed to us. This material includes, but is not limited to, the design, layout, look, appearance and graphics. Reproduction is prohibited other than in accordance with the copyright notice, which forms part of these terms and conditions.

All trademarks reproduced in this website, which are not the property of, or licensed to the operator, are acknowledged on the website.

Unauthorized use of this website may give rise to a claim for damages and/or be a criminal offence.

From time to time, this website may also include links to other websites. These links are provided for your convenience to provide further information. They do not signify that we endorse the website(s). We have no responsibility for the content of the linked website(s).

Your use of this website and any dispute arising out of such use of the website is subject to the laws of Canada and USA.

We use cookies to make this site as useful as possible. They are small text files we put in your browser to track usage of our site but they don’t tell us who you are. If you want to delete any cookies that are already on your computer, please refer to the instructions for your file management software to locate the file or directory that stores cookies.

This site is not a part of the Facebook website or Facebook Inc. Additionally, this site is not endorsed by Facebook in any way. FACEBOOK is a trademark of FACEBOOK, Inc.